COVINGTON, Ky., 2017-12-07 21:00 CET (GLOBE NEWSWIRE) --
CTI Clinical Trial and Consulting Services (CTI), a global, privately held,
full-service contract research organization announces the acquisition of
Eurotrials, a full-service contract research organization, with more than 20
years of experience, and strong local expertise in Europe and Latin America.
The acquisition strengthens CTI's existing Real World Evidence business, adding
significant presence and expertise in Europe and Latin America. Eurotrials has
offices in Argentina, Brazil, Chile, Mexico, Peru, Portugal and Spain, covering
over 15 countries in both regions. Eurotrials provides an extensive array of
services from early- to late-stage research as well as product support in
accordance with global and specific regional requirements. Additionally, the
Eurotrials footprint augments CTI's current reach, enabling CTI to better serve
clients and global programs.
"We are excited to join our companies together to create a stronger
full-service global clinical research organization," according to Timothy J.
Schroeder, CTI Founder and CEO. "This combined company will be one of the 20
largest CROs in the world, with associates in more than 30 countries across six
continents. We believe this combined entity is the oldest, largest, privately
owned CRO in the world with the founders still active in the company
operations. We're also thrilled that the leaders of Eurotrials, Maria João
Queiroz and Inês Costa, will continue to play a large role in the
organization."
"We are very pleased with the opportunity to combine strengths and expertise
with CTI," according to Maria João Queiroz, MD, Founder and CEO of Eurotrials.
"Our companies have a strong cultural fit and a similar approach to clients and
collaborators. Joining CTI enhances the access our clients have to industry
leading therapeutic expertise, a broader global footprint, and a greater
capacity for innovative solutions, while still maintaining focus on the local
and regional proximity to our clients, as well as the quality and customer
service that is highly valued by Eurotrials clients."
The terms of the acquisition were not disclosed. Plante Moran and Fifth Third
Bank provided support to CTI throughout the acquisition.
About CTI Clinical Trial and Consulting Services
CTI Clinical Trial and Consulting Services is a global, privately held,
full-service contract research organization (CRO), delivering a complete
spectrum of clinical trial and consulting services throughout the lifecycle of
development, from concept to commercialization, including real world evidence.
CTI's focused therapeutic approach provides pharmaceutical, biotechnology, and
medical device firms with clinical and disease area expertise in rare diseases,
regenerative medicine/gene therapy, immunology, transplantation, nephrology,
hematology/oncology, neurology, infectious diseases, hematology,
cardiopulmonary, and pediatric populations. CTI also offers a fully integrated
multi-specialty clinical research site that conducts phase I-IV trials. CTI has
a passion for helping life-changing therapies succeed in chronically and
critically ill patient populations. With clinical trial experience across 6
continents, CTI partners with research sites, patients, and sponsors to fulfill
unmet medical needs. CTI is headquartered in the Greater Cincinnati, OH area,
with operations across North America, Europe, Latin America, and Asia-Pacific.
For more information visit www.ctifacts.com
Media Contact: Allison Schroeder - 513.598.9290 ?
aschroeder@ctifacts.com© 2017 GlobeNewswire
